Critical Outcome Technologies Inc.
OTCQB: COTQF
TSX-V: COT
BLOG
  • Home
  • About
    • Overview
    • Leadership
      • Management
      • Board of Directors
      • Scientific Advisory Board
    • Partnerships
    • Careers
    • Kasyno Bez Weryfikacji 2025
    • Siti Non Aams
    • List Of Casinos Not On Gamstop
  • COTI-2 and Pipeline
    • COTI-2
    • Pipeline
    • Other Products
  • Technology
    • CHEMSAS®
    • ROSALIND
    • CHEMFirm
  • Investors
    • Overview
    • Connect
    • Events
    • News
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Financials
    • Presentations and Factsheets
    • Shareholder Information
    • Corporate Governance
  • Contact
  • OTCQB: COTQF
    TSX-V: COT
    BLOG

2013

2013

December 18, 2013

Critical Outcome Technologies Reports Second Quarter Results

December 6, 2013

Critical Outcome Technologies Awards Stock Options

December 6, 2013

Critical Outcome Technologies Provides Business and Scientific Update at Annual General Meeting

December 5, 2013

Annual General Meeting Presentation

November 13, 2013

COTI-2, a P53 Dependent Treatment for Many Common Cancers, Recieves Additional U.S. Patent Protection

October 29, 2013

Critical Outcome Technologies Announces Warrant Expiry Data Amendment

October 15, 2013

Critical Outcome Technologies Grants Stock Options

October 4, 2013

Notice of Annual General and Special Meeting

October 3, 2013

Critical Outcome Technologies To Present at the 12th Annual BIO Investor Forum

September 27, 2013

Critical Outcome Technologies Reports Fiscal 2014 First Quarter Results

September 11, 2013

Critical Outcome Technologies Announces Warrant Term Amendments

September 4, 2013

Critical Outcome Technologies Files Revised 2013 Annual Financial Statements Due To Clerical Error

August 30, 2013

Critical Outcome Technologies Completes Final Tranche of Private Placement

August 28, 2013

Critical Outcome Technologies Completes Private Placement

August 27, 2013

Critical Outcome Technologies Reports Year-End Financial and Operating Results

August 16, 2013

Critical Outcome Technologies Inc. Completes Financing

June 24, 2013

Critical Outcome Technologies Inc. Completes Financing

June 11, 2013

Promising Advance for Many Common Cancers

June 3, 2013

Critical Outcome Technologies Inc. Completes Financing

May 6, 2013

Artificial Intelligence-Based Technology Yielding Positive Results in Drug Discovery Collaborations

April 26, 2013

Additional U.S. Patents for Lead Cancer Drug Candidate Strengthen Critical Outcome’s Investment Proposition

April 19, 2013

Critical Outcome Technologies Inc. Presenting at the 2013 BIO International Convention

April 16, 2013

Critical Outcome Technologies Inc. Strengthens Investor Communications

April 9, 2013

Critical Outcome Technologies Inc. Provides Important Update on AML Program

April 2, 2013

Critical Outcome Technologies Inc. Retains Market-Making Services

March 28, 2013

Critical Outcome Technologies Inc. Reports Fiscal 2013 Third Quarter Financial Results

January 31, 2013

Critical Outcome Technologies Inc. Completes Financing

January 29, 2013

Critical Outcome Technologies Inc. Announces Warrant Term Amendment

  • Overview
  • Connect
  • Stock Information
  • Events
  • News
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
  • Financials
  • Presentations and Factsheets
  • Analyst Coverage
  • Shareholder Information
  • Corporate Governance

Sign Up

Sign up to receive the latest press releases from COTI





* Required

Subscribe

  • About
    Overview
  • Leadership
    Management
  • Board of Directors
  • Scientific Advisory Board
  • Partnerships
  • Careers
  • COTI-2 and Pipeline
    COTI-2
  • Pipeline
  • Other Products
  • Technology
    CHEMSAS®
  • ROSALIND
  • Investors
    Overview
  • Connect
  • Events
  • News
    2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • Financials
  • Presentations and Factsheets
  • Shareholder Information
  • Corporate Governance
  • Contact
  • Careers

    COTI is an exciting, rapidly growing biopharmaceutical company and we are always looking for talented, committed individuals that are interested in using cutting edge technology to improve the lives of people.

    Learn More

    Awards

    Best in class award for COTI website
    © Critical Outcome Technologies 2017
    Designed & Powered by Blender
    Privacy Policy
      |  Terms of Use & Disclaimer